본문 바로가기
KERD
논문KCI 등재

Disk Diffusion Susceptibility Testing for the Rapid Detection of Fluconazole Resistance in Candida Isolates

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Given the increased fluconazole resistance (FR) among Candida isolates, we assessed the suitability of disk diffusion susceptibility testing (DDT) for the early detection of FR using well-characterized Candida isolates. Methods: In total, 188 Candida isolates, including 66 C. albicans (seven Erg11 mutants), 69 C. glabrata (33 Pdr1 mutants), 29 C. parapsilosis (15 Erg11 mutants), and 24 C. tropicalis (eight Erg11 mutants) isolates, were tested in this study. FR was assessed using DDT according to the standard CLSI M44-ED3 method, except that two cell suspensions, McFarland 0.5 (standard inoculum) and 2.5 (large inoculum), were used, and the inhibition zones were read at 2-hour intervals from 10 hours to 24 hours. Results: DDT results for the standard inoculum were readable after 14 hours (C. albicans, C. glabrata, and C. tropicalis) and 20 hours (C. parapsilosis) for >95% of the isolates, whereas the results for the large inoculum were readable after 12 hours (C. glabrata and C. tropicalis), 14 hours (C. albicans), and 16 hours (C. parapsilosis) for >95% of the isolates. Compared with the results produced using the CLSI M27-ED4 broth microdilution method, the first readable results from the DDT method for each isolate exhibited an agreement of 97.0%, 98.6%, 72.4%, and 91.7% for the standard inoculum and 100%, 98.6%, 96.6%, and 95.8% for the large inoculum for C. albicans, C. glabrata, C. parapsilosis, and C. tropicalis, respectively. Conclusions: DDT using large inoculum may detect FR rapidly and reliably in the four most common Candida species.

Abstract

Background: Given the increased fluconazole resistance (FR) among Candida isolates, we assessed the suitability of disk diffusion susceptibility testing (DDT) for the early detection of FR using well-characterized Candida isolates. Methods: In total, 188 Candida isolates, including 66 C. albicans (seven Erg11 mutants), 69 C. glabrata (33 Pdr1 mutants), 29 C. parapsilosis (15 Erg11 mutants), and 24 C. tropicalis (eight Erg11 mutants) isolates, were tested in this study. FR was assessed using DDT according to the standard CLSI M44-ED3 method, except that two cell suspensions, McFarland 0.5 (standard inoculum) and 2.5 (large inoculum), were used, and the inhibition zones were read at 2-hour intervals from 10 hours to 24 hours. Results: DDT results for the standard inoculum were readable after 14 hours (C. albicans, C. glabrata, and C. tropicalis) and 20 hours (C. parapsilosis) for >95% of the isolates, whereas the results for the large inoculum were readable after 12 hours (C. glabrata and C. tropicalis), 14 hours (C. albicans), and 16 hours (C. parapsilosis) for >95% of the isolates. Compared with the results produced using the CLSI M27-ED4 broth microdilution method, the first readable results from the DDT method for each isolate exhibited an agreement of 97.0%, 98.6%, 72.4%, and 91.7% for the standard inoculum and 100%, 98.6%, 96.6%, and 95.8% for the large inoculum for C. albicans, C. glabrata, C. parapsilosis, and C. tropicalis, respectively. Conclusions: DDT using large inoculum may detect FR rapidly and reliably in the four most common Candida species.

참고문헌 (26)

  1. Kullberg BJ, "Invasive candidiasis", N Engl J Med, 373, pp.1445~1456 (2015)
  2. Ha Jin Lim, "First Case of Nosocomial Fungemia Caused by Candida melibiosica", Annals of Laboratory Medicine, 40(2), pp.177~179 (2020), 대한진단검사의학회[DOI]
  3. Pfaller MA, "Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997–2016", Open Forum Infect Dis, 6(S1), pp.S79~S94 (2016)
  4. Arendrup MC, "Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment", J Infect Dis, 216(S3), pp.S445~S451 (2017)
  5. Pappas PG, "Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America", Clin Infect Dis, 62, pp.e1~e50 (2016)
  6. Castanheira M, "Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cutoff values and whole-genome sequencing analysis for detection of azole resistance in Candida albicans", Antimicrob Agents Chemother, 61, pp.e00906~e00917 (2017)
  7. Choi YJ, "Fluconazole-resistant Candida parapsilosis bloodstream isolates with Y132F mutation in ERG11 gene, South Korea", Emerg Infect Dis, 24, pp.1768~1770 (2018)
  8. Berkow EL, "Antifungal susceptibility testing: current approaches", Clin Microbiol Rev, 33, pp.e00069-19~ (2020)
  9. van den Bijllaardt W, "Shortening the incubation time for antimicrobial susceptibility testing by disk diffusion for Enterobacteriaceae: how short can it be and are the results accurate?", Int J Antimicrob Agents, 49, pp.631~637 (2017)
  10. Jabeen K, "Agreement of direct antifungal susceptibility testing from positive blood culture bottles with the conventional method for Candida species", J Clin Microbiol, 54, pp.343~348 (2016)
  11. Oz Y, "Evaluation of direct antifungal susceptibility testing methods of Candida spp. from positive blood culture bottles", J Clin Lab Anal, 32, pp.e22297~ (2018)
  12. Jonasson E, "The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles", J Antimicrob Chemother, 75, pp.968~978 (2020)
  13. Meis J, "A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group", Diagn Microbiol Infect Dis, 36, pp.215~223 (2000)
  14. Pfaller MA, "Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001", J Clin Microbiol, 41, pp.1440~1446 (2003)
  15. CLSI, "Reference method for broth dilution antifungal susceptibility testing of yeasts" (2017), Clinical and Laboratory Standards Institute
  16. CLSI, "Performance standards for antifungal susceptibility testing of yeasts" (2020), Clinical and Laboratory Standards Institute
  17. 이현승, "Comparison of the Bruker Biotyper and VITEK MS Matrix- Assisted Laser Desorption", Ionization Time-of-Flight Mass Spectrometry Systems Using a Formic Acid Extraction Method to Identify Common and Uncommon Yeast Isolates, 2017, pp.37(3), 223~230[DOI]
  18. Byun SA, "Multilocus sequence typing (MLST) genotypes of Candida glabrata bloodstream isolates in Korea: association with antifungal resistance, mutations in mismatch repair gene (Msh2), and clinical outcomes", Front Microbiol, 9, pp.1523~ (2018)
  19. Lim HJ, "Evaluation of two commercial broth microdilution methods using different interpretive criteria for the detection of molecular mechanisms of acquired azole and echinocandin resistance in four common Candida species", Antimicrob Agents Chemother, 64, pp.e00740-20~ (2020)
  20. Morio F, "Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans", Int J Antimicrob Agents, 42, pp.410~415 (2013)
  21. Arastehfar A, "Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1", Antimicrob Agents Chemother, 63, pp.e02503~e02518 (2019)
  22. Choi MJ, "Resistance mechanisms and clinical features of fluconazole-nonsusceptible Candida tropicalis isolates compared with fluconazole-less-susceptible isolates", Antimicrob Agents Chemother, 60, pp.3653~3661 (2016)
  23. CLSI, "Method for antifungal disk diffusion susceptibility testing of yeasts" (2018), Clinical and Laboratory Standards Institute
  24. Kumar H, "Optimization of protocol for disc diffusion of antifungal drugs directly from blood culture bottles positive for Candida species", Infect Dis J Pak, 24, pp.809~812 (2015)
  25. Chang HC, "Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures", J Clin Microbiol, 39, pp.1328~1333 (2001)
  26. Humphries RM, "CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests", J Clin Microbiol, 56, pp.e01934-17~ (2018)

관련 논문AI추천

Fluconazole 첨가 사브로덱스트로오스 한천 배지를 사용한 Candida 종의 Fluconazole 내성 검색김태형, 이미경대한의진균학회 · 대한의진균학회지2009 · 제14권 제1호Using the Sensititre YeastOne, Vitek 2 System and Disk Diffusion for Antifungal Susceptibility Testing of Candida Species Isolated from Patients in ThailandChutipapa Sukkasem, Kanuengnit Srisak, Kittipan Samerpitak, Lumyai Wonglakorn, Rungsima Methachaiphatkun, Waewta Kuwatjanakul대한의진균학회 · 대한의진균학회지2025 · 제30권 제3호In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values김미나, 김수현, 서순팔, 송은송, 신명근, 신종희, 양동욱, 이경원, 이미경, 이위교, 이혜수, 장민중, 장철훈, 장희창대한진단검사의학회 · Annals of Laboratory Medicine2013 · 제33권 제3호임상검체에서 분리된 칸디다 균종에서2,3-Diphenyl-5-Thienyl-(2)-Tetrazolium Chloride 비색법을 이용한Fluconazole 항진균제 감수성 검사의 평가김재현, 김혜란, 신정환, 이은정, 이자영, 이정녀, 장철훈대한임상미생물학회 · Annals of Clinical Microbiology2007 · 제10권 제2호Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis김희수, 서무규, 송유범, 하경임대한피부과학회 · Annals of Dermatology2015 · 제27권 제6호Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea김수현, 박연준, 신종희, 이경원, 이위교, 정숙인, 주민영, 최현정대한진단검사의학회 · Annals of Laboratory Medicine2012 · 제32권 제6호

이 간행물의 다른 논문 (14건)